Elutia (NASDAQ:ELUT – Get Free Report) will be posting its quarterly earnings results after the market closes on Thursday, May 9th. Individual that wish to register for the company’s earnings conference call can do so using this link.
Elutia (NASDAQ:ELUT – Get Free Report) last posted its quarterly earnings data on Thursday, March 7th. The company reported ($0.66) earnings per share for the quarter. The business had revenue of $5.88 million during the quarter.
Elutia Stock Performance
Elutia stock opened at $2.90 on Wednesday. The stock’s 50 day simple moving average is $3.12 and its two-hundred day simple moving average is $2.73. The stock has a market cap of $70.38 million, a price-to-earnings ratio of -1.37 and a beta of 0.56. Elutia has a fifty-two week low of $1.10 and a fifty-two week high of $4.19.
About Elutia
Elutia Inc, a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators.
Recommended Stories
- Five stocks we like better than Elutia
- What Does Downgrade Mean in Investing?
- Garmin Navigates to New Highs Driven By Wearables Trend
- Stock Splits, Do They Really Impact Investors?
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- Find and Profitably Trade Stocks at 52-Week Lows
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Elutia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elutia and related companies with MarketBeat.com's FREE daily email newsletter.
